Schedule 13D ownership disclosure
Whitehawk Therapeutics, Inc.
Common stock, par value $0.0001 per share · CUSIP: 00032Q104
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AVORO CAPITAL ADVISORS LLCReported CIK 0001633313
Shares: 2,849,402.00 · Class: 11.6%
- AVORO VENTURES LLCReported CIK 0001879253
Shares: 622,350.00 · Class: 2.5%
- BEHZAD AGHAZADEHReported CIK 0001701815
Shares: 3,581,961.00 · Class: 14.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-007000
- Form type
- SCHEDULE 13D/A
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Dec 23, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13D beneficial ownership